DREAM3R: Durvalumab with chemotherapy as first line treatment in advanced pleural mesothelioma - a phase 3 randomised trial Meeting Abstract
| Authors: | Forde, P.; Stockler, M.; Kok, P. S.; Brown, C.; Sun, Z.; O'Byrne, K.; Yip, S.; Anagnostou, V.; Cook, A.; Lesterhuis, W. J.; Hughes, B.; Kindler, H.; Tsao, A.; Zauderer, M.; Bricker, A.; Oostendorp, M.; Marinucci, D.; Fitzpatrick, K.; Ford, K.; Pavlakis, N.; Brahmer, J.; Ramalingam, S.; Nowak, A. |
| Abstract Title: | DREAM3R: Durvalumab with chemotherapy as first line treatment in advanced pleural mesothelioma - a phase 3 randomised trial |
| Meeting Title: | 2021 World Conference on Lung Cancer |
| Keywords: | immunotherapy; mesothelioma; durvalumab |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 16 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2021 Sep 8-14 |
| Meeting Location: | Virtual event |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-10-01 |
| Start Page: | S957 |
| Language: | English |
| ACCESSION: | WOS:000709606500230 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2021.08.230 |
| Notes: | Meeting Abstract: FP07.05 -- Source: Wos |
